PFSA - צמיחת הכנסות ב-12 חודשים נגררים Profusa, Inc

High patent barriers and strict FDA oversight limit the entry of new players into the sector. Current trailing 12-month revenue dynamics show that 0.00 is the current level of the indicator. Profusa Inc revenues are based on the sale of sensors for endocrinologists and individuals with metabolic disorders. Growth relies on a systematic R&D pipeline for the creation of biomarker monitoring systems.
profusa.com (PFSA) - פילוחי מדדים ודוחות פיננסיים

This indicator measures revenue dynamics over a rolling four-quarter period relative to the same period last year. This methodology smooths out seasonality, allowing investors to assess the actual business resilience between reports. For Profusa Inc (PFSA), this growth rate reflects the commercialization of unique hydrogel-based biosensors. When analyzing the rolling year-over-year sales growth trajectory on GURU.Markets, it is critical to account for the risk of a low base effect.